Table 2 Age of vaccine administration in preterm group compared to recommended timelines (Wilcoxon Signed Rank test)
Vaccine | Preterm group | Recommended age (days) | p |
|---|---|---|---|
Median (IQR) | value | ||
DTaP-IPV-HBV-Hib 1 doses | 99.0 (45.0) | 61.0 | < 0.001 |
DTaP-IPV-HBV-Hib 2 doses | 184.0 (79.0) | 121.0 | < 0.001 |
DTaP-IPV-HBV-Hib 3 doses | 395.0 (101.0) | 336.0 | < 0.001 |
PCV 1 doses | 104.0 (47.0) | 61.0 | < 0.001 |
PCV 2 doses | 183.5 (73.3) | 121.0 | < 0.001 |
PCV 3 doses | 394.5 (85.5) | 336.0 | < 0.001 |
Men C | 506.0 (116.0) | 366.0 | < 0.001 |
MMR | 454.5 (131.0) | 426.0 | < 0.001 |
Varicella | 454.5 (131.0) | 366.0 | < 0.001 |